These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3210303

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M.
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the field of pediatrics].
    Haruta T, Okura KE, Kuroki S, Yamamoto H, Yamaoka K, Kubo K, Kobayashi Y.
    Jpn J Antibiot; 1986 Jul; 39(7):1879-88. PubMed ID: 2945941
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
    Tsukada T, Katayama N, Kageyama S, Nishikawa M, Kobayashi T, Deguchi K, Shirakawa S, Minami N.
    Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
    [Abstract] [Full Text] [Related]

  • 29. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
    Tsuda S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Horiike S, Taniwaki M, Misawa S, Kashima K.
    Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
    [Abstract] [Full Text] [Related]

  • 30. Imipenem/cilastatin as secondary therapy for bacterial infections.
    Kono K, Onuki K, Tohara S, Takeda S.
    Clin Ther; 1991 Feb; 13(4):448-56. PubMed ID: 1933995
    [Abstract] [Full Text] [Related]

  • 31. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S, Suzuki M, Hasegawa Y, Ninomiya K, Shimizu T, Maeda Y, Ichinoe K, Makinoda S, Sato H, Sato H.
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [Abstract] [Full Text] [Related]

  • 32. [Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients].
    Yamamoto M, Ina Y, Takada K, Noda M, Morishita M, Senda Y, Torii Y, Kakihara H, Yoshikawa K, Sugiura T.
    Jpn J Antibiot; 1991 Apr; 44(4):388-97. PubMed ID: 1652653
    [Abstract] [Full Text] [Related]

  • 33. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
    Fukuhara H, Kusano N, Nakamura H, Kaneshima H, Irabu Y, Shimozi K, Kitukawa K, Shigeno Y, Saito A, Kakazu T.
    Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
    [Abstract] [Full Text] [Related]

  • 34. [Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
    Bégué P, Quinet B, Baron S, Challier P, Fontaine JL, Lasfargues G.
    Pathol Biol (Paris); 1989 May; 37(5):485-90. PubMed ID: 2674874
    [Abstract] [Full Text] [Related]

  • 35. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R, Meguro H, Arimasu O, Yoshioka H, Fujita K, Maruyama S, Inyaku F, Nagamatsu I, Wagatsuma Y, Takase A.
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [Abstract] [Full Text] [Related]

  • 36. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Matsuda S, Oh K, Tateno M, Kojima Y, Hirabayashi K, Okada E, Doko F, Kawai J.
    Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
    [Abstract] [Full Text] [Related]

  • 37. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
    Takamoto M, Ishibashi T, Toyoshima H, Tanaka H, Tamaru N, Watanabe K, Yoshida M, Tokunaga N, Ichikawa Y, Oizumi K.
    Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255
    [Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases.
    Cristiano P, Iovene MR, Simioli F, Pezza M, Raucci G, Lobello R.
    Drugs Exp Clin Res; 1990 Sep; 16(6):293-7. PubMed ID: 2086164
    [Abstract] [Full Text] [Related]

  • 39. [Fundamental and clinical studies of imipenem and imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Hirabayashi K, Okada E.
    Jpn J Antibiot; 1986 May; 39(5):1413-25. PubMed ID: 3463787
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.